Source: Annual Congress 2006 - Airway cell biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. M. Hughes, H. Alkhouri, E. Chen, Y. Alrashdan, Q. Ge, C. L. Armour, S. Henness, A. J. Ammit (Sydney, Australia). Asthmatic and non-asthmatic airway smooth muscle production of the mast cell chemotaxin CXCL10 involves MAPK. Eur Respir J 2006; 28: Suppl. 50, 4925

Member's Comments

No comment yet.

Related content which might interest you: Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells Source: Eur Respir J 2006; 28: Suppl. 50, 339s Year: 2006 Transcriptional regulation of CXCL8 hypersecretion in asthmatic airway smooth muscle cells Source: Annual Congress 2009 - Airway cell biology Year: 2009 Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Rolipram and salmeterol block β1/β2-integrin-mediated adhesion of eosinophils to cultured airway smooth muscle cells from non-asthmatic and asthmatic donors Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle Source: Eur Respir J 2004; 24 : 559-567 Year: 2004 TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells Source: ERJ Open Res, 6 (4) 00147-2020; 10.1183/23120541.00147-2020 Year: 2020 Role of Rho kinase isoforms in murine allergic airway responses Source: Eur Respir J 2011; 38: 841-850 Year: 2011 IgE-induced pro-inflammatory extracellular matrix composition in airway smooth muscle cells is prevented by omalizumab Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Airway smooth muscle-derived fractalkine needs VIP to induce mast cell chemotaxis Source: Eur Respir J 2005; 26: Suppl. 49, 128s Year: 2005 Omalizumab inhibits IgE-induced extracellular matrix deposition by asthmatic airway smooth muscle cells Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 Contribution of bronchial smooth muscle to inflammation Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease Year: 2005 Histamine and tryptase modulate asthmatic airway smooth muscle GM-CSF and RANTES release Source: Eur Respir J 2007; 29: 861-870 Year: 2007 Effects of IL-5 and IL-13 on human airway smooth muscle migration, proliferation and cytokine synthesis Source: Eur Respir J 2005; 26: Suppl. 49, 128s Year: 2005 Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018 Year: 2018 Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002